Best for
Mobile
How to buy AgeX Therapeutics shares | $2.08
Own AgeX Therapeutics shares in just a few minutes. Share price changes are updated daily.
AgeX Therapeutics, Inc (AGE) is a leading biotechnology business based in the US. It opened the day at $2.2 after a previous close of $2.23. During the day the price has varied from a low of $2.08 to a high of $2.2369. The latest price was $2.08 (25 minute delay). AgeX Therapeutics is listed on the NYSE MKT and employs 17 staff. All prices are listed in US Dollars.
How to buy shares in AgeX Therapeutics
- Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: AGE in this case.
- Research AgeX Therapeutics shares. The platform should provide the latest information available.
- Buy your AgeX Therapeutics shares. It's that simple.
Best for
Low-cost
Best for
Beginners
Best for
Funds
What's in this guide?
- Can I buy shares in AgeX Therapeutics?
- AgeX Therapeutics shares summary
- Compare share dealing platforms
- Is AgeX Therapeutics stock a buy or sell?
- AgeX Therapeutics performance over time
- Can I short AgeX Therapeutics shares?
- AgeX Therapeutics's financials
- How volatile are AgeX Therapeutics shares?
- Does AgeX Therapeutics pay a dividend?
- Have AgeX Therapeutics shares ever split?
- Other common questions
AgeX Therapeutics share price
Use our graph to track the performance of AGE stocks over time.AgeX Therapeutics shares at a glance
Information last updated 2021-03-05.
| Open | $2.2 |
|---|---|
| High | $2.2369 |
| Low | $2.08 |
| Close | $2.08 |
| Previous close | $2.23 |
| Change | $-0.15 |
| Change % | -6.7265% |
| Volume | 239,836 |
Information last updated 2021-03-03.
| 52-week range | $0.666 - $3.06 |
|---|---|
| 50-day moving average | $2.1003 |
| 200-day moving average | $1.577 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.318 |
Invest in AgeX Therapeutics shares with 0% commission
Other fees may apply. Your capital is at risk.
- Unlimited trades, with no dealing charges or management fees
- If your trades get copied you can earn extra money
- Create an account today in a few minutes
Go to site
Capital at risk
Fees for buying 100x AgeX Therapeutics shares with popular platforms
Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.
| Platform | Platform fee | Min. initial deposit | Trading fee estimate | |
|---|---|---|---|---|
|
£0 | No minimum | £4.39 £154.94 total |
Capital at risk |
|
£0 | $500 | £0.75 £151.30 total |
Capital at risk |
 |
£0 | £0.01 | £0.87 £151.42 total |
Capital at risk |
 |
£0 | £50 | £1.04 £151.59 total |
Capital at risk |
|
£0 | £1 | £13.75 £164.30 total |
Capital at risk |
|
£9.99 per month | No minimum | £10.54 £161.09 total |
Capital at risk |
 |
£0 | £20 | £14.67 £165.22 total |
Capital at risk |
Full comparison of share dealing platforms
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Is it a good time to buy AgeX Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
AgeX Therapeutics price performance over time
Historical closes compared with the last close of $2.08
| 1 week (2021-02-25) | -0.72% |
|---|---|
| 1 month (2021-02-05) | -0.95% |
| 3 months (2020-12-04) | 22.35% |
| 6 months (2020-09-04) | 160.33% |
| 1 year (2020-03-04) | 84.07% |
|---|---|
| 2 years (2019-03-04) | -49.88% |
AgeX Therapeutics financials
| Revenue TTM | $1.9 million |
|---|---|
| Gross profit TTM | $1.5 million |
| Return on assets TTM | -110.41% |
| Return on equity TTM | -1881.2% |
| Profit margin | 0% |
| Book value | $0.115 |
| Market capitalisation | $95 million |
TTM: trailing 12 months
How to short and sell AgeX Therapeutics shares
- Create a CFD or spread betting account.
- Search for the stock code. E.g. "AGE.US"
- Choose your position size.
- Select "sell" rather than "buy".
- Confirm your position and keep tabs on it. You may wish to set limits on your position.
There are currently 407,255 AgeX Therapeutics shares held short by investors – that's known as AgeX Therapeutics's "short interest". This figure is 12% up from 363,471 last month.
There are a few different ways that this level of interest in shorting AgeX Therapeutics shares can be evaluated.
AgeX Therapeutics's "short interest ratio" (SIR)
AgeX Therapeutics's "short interest ratio" (SIR) is the quantity of AgeX Therapeutics shares currently shorted divided by the average quantity of AgeX Therapeutics shares traded daily (recently around 490668.6746988). AgeX Therapeutics's SIR currently stands at 0.83. In other words for every 100,000 AgeX Therapeutics shares traded daily on the market, roughly 830 shares are currently held short.
However AgeX Therapeutics's short interest can also be evaluated against the total number of AgeX Therapeutics shares, or, against the total number of tradable AgeX Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case AgeX Therapeutics's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 AgeX Therapeutics shares in existence, roughly 10 shares are currently held short) or 0.0192% of the tradable shares (for every 100,000 tradable AgeX Therapeutics shares, roughly 19 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against AgeX Therapeutics.
Find out more about how you can short AgeX Therapeutics stock.
AgeX Therapeutics share dividends
We're not expecting AgeX Therapeutics to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
Have AgeX Therapeutics's shares ever split?
AgeX Therapeutics's shares were split on a 15:16 basis on 6 May 2015. So if you had owned 16 shares the day before before the split, the next day you'd have owned 15 shares. This wouldn't directly have changed the overall worth of your AgeX Therapeutics shares – just the quantity. However, indirectly, the new 6.7% higher share price could have impacted the market appetite for AgeX Therapeutics shares which in turn could have impacted AgeX Therapeutics's share price.
AgeX Therapeutics share price volatility
Over the last 12 months, AgeX Therapeutics's shares have ranged in value from as little as $0.666 up to $3.06. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while AgeX Therapeutics's is 1.4498. This would suggest that AgeX Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Win £500 to get your trading started
Subscribe to trending stock alerts for a chance to win
AgeX Therapeutics overview
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-related metabolic disorders, such as Type II adult-onset diabetes; and AGEX-VASC1, a cell-based therapy to restore vascular support in aged ischemic tissues, such as the ischemic heart. Its lead drug-based therapeutic candidate in discovery is AGEX-iTR1547, a drug-based formulation to restore regenerative potential in a range of aged tissues afflicted with degenerative diseases. In addition, the company markets human embryonic stem cells; and GeneCards Database Suite, including genomic interpretation algorithms and analysis tools for use by researchers at pharmaceutical and biotechnology companies, and other institutions. AgeX Therapeutics, Inc. has a research collaboration with the University of California, Irvine on neural stem cell research program for Huntington's disease and other neurological disorders; and Sernova Corp. The company was founded in 2017 and is based in Alameda, California.
Frequently asked questions
More guides on Finder
-
How to buy Vroom shares | $27.97
Learn more about Vroom’s recent performance and where you can invest in Vroom shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Washington Prime shares | $1.87
Learn more about Washington Prime Group’s recent performance and where you can invest in Washington Prime shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Vertu Capital shares | 1.75p
Learn more about Vertu Capital’s recent performance and where you can invest in Vertu Capital shares. We also run through some helpful rules of thumb for any investor.
-
How to buy ReTo Eco-Solutions shares | $1.66
Learn more about ReTo Eco-Solutions’ recent performance and where you can invest in ReTo Eco-Solutions shares. We also run through some helpful rules of thumb for any investor.
-
How to buy RCI Hospitality Holdings shares
Ever wondered how to buy shares in RCI Hospitality Holdings? We explain how and compare a range of providers that can give you access to many brands, including RCI Hospitality Holdings.
-
How to buy Norfolk Southern shares
Ever wondered how to buy shares in Norfolk Southern? We explain how and compare a range of providers that can give you access to many brands, including Norfolk Southern.
-
How to buy ResMed shares
Ever wondered how to buy shares in ResMed? We explain how and compare a range of providers that can give you access to many brands, including ResMed.
-
How to buy Motorola Solutions shares
Ever wondered how to buy shares in Motorola Solutions? We explain how and compare a range of providers that can give you access to many brands, including Motorola Solutions.
-
How to buy Kinder Morgan shares
Ever wondered how to buy shares in Kinder Morgan? We explain how and compare a range of providers that can give you access to many brands, including Kinder Morgan.
-
How to buy Enterprise Products Partners shares
Ever wondered how to buy shares in Enterprise Products Partners? We explain how and compare a range of providers that can give you access to many brands, including Enterprise Products Partners.
Ask an Expert